Developing Growth Fund
Daily price w/o sales charge as of 01/30/2026
$26.61
$0.79
YTD Returns w/o sales charge as of 01/30/2026
3.82%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 12/31/2025
- Total Net Assets
- $1.98 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 0.94%
- Fund Net Expense Ratio
- 0.94%
- Number of Holdings
- 77
- Minimum Initial Investment
- $1,000+
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 14.37% | 14.37% | 14.79% | -1.21% | 11.02% | 10.54% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell 2000® Growth Index | 13.01% | 13.01% | 15.59% | 3.18% | 9.57% | - |
| w/ sales charge | 7.78% | 7.78% | 12.55% | -2.37% | 10.37% | 10.41% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 14.37% | 14.37% | 14.79% | -1.21% | 11.02% | 10.54% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell 2000® Growth Index | 13.01% | 13.01% | 15.59% | 3.18% | 9.57% | - |
| w/ sales charge | 7.78% | 7.78% | 12.55% | -2.37% | 10.37% | 10.41% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 12/31/2025View Portfolio
| Holding | Assets |
|---|---|
| Guardant Health Inc | 3.7% |
| Credo Technology Group Holding Ltd | 3.0% |
| Comfort Systems USA Inc | 2.6% |
| Madrigal Pharmaceuticals Inc | 2.4% |
| Bridgebio Pharma Inc | 2.2% |
| Carpenter Technology Corp | 2.1% |
| Reddit Inc | 1.9% |
| Modine Manufacturing Co | 1.9% |
| GeneDx Holdings Corp | 1.9% |
| Kratos Defense & Security Solutions Inc | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2025View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 14.37% | 14.37% | 14.79% | -1.21% | 11.02% | 10.54% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell 2000® Growth Index | 13.01% | 13.01% | 15.59% | 3.18% | 9.57% | - |
| w/ sales charge | 7.78% | 7.78% | 12.55% | -2.37% | 10.37% | 10.41% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 14.37% | 14.37% | 14.79% | -1.21% | 11.02% | 10.54% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell 2000® Growth Index | 13.01% | 13.01% | 15.59% | 3.18% | 9.57% | - |
| w/ sales charge | 7.78% | 7.78% | 12.55% | -2.37% | 10.37% | 10.41% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2025 | 14.37% | 13.01% |
| 2024 | 21.89% | 15.15% |
| 2023 | 8.50% | 18.66% |
| 2022 | -36.09% | -26.36% |
| 2021 | -2.66% | 2.83% |
| 2020 | 72.57% | 34.63% |
| 2019 | 31.91% | 28.48% |
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | - |
| 2014 | 3.25% | - |
| 2013 | 57.19% | - |
| 2012 | 10.39% | - |
| 2011 | -1.66% | - |
| 2010 | 36.54% | - |
| 2009 | 47.03% | - |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | - | - | - | - |
| 2025 | -17.67% | 20.16% | 13.71% | 1.67% |
| 2024 | 12.62% | 0.92% | 6.32% | 0.88% |
| 2023 | 8.32% | 3.27% | -12.97% | 11.45% |
| 2022 | -19.27% | -21.16% | 0.59% | -0.18% |
| 2021 | 1.64% | 2.87% | -3.66% | -3.35% |
| 2020 | -16.91% | 40.59% | 15.92% | 27.45% |
| 2019 | 27.01% | 9.09% | -11.35% | 7.39% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 12/31/2025
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Guardant Health Inc | Health Care | 3.7% |
| Credo Technology Group Holding Ltd | Information Technology | 3.0% |
| Comfort Systems USA Inc | Industrials | 2.6% |
| Madrigal Pharmaceuticals Inc | Health Care | 2.4% |
| Bridgebio Pharma Inc | Health Care | 2.2% |
| Carpenter Technology Corp | Industrials | 2.1% |
| Reddit Inc | Communication Services | 1.9% |
| Modine Manufacturing Co | Industrials | 1.9% |
| GeneDx Holdings Corp | Health Care | 1.9% |
| Kratos Defense & Security Solutions Inc | Industrials | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Guardant Health Inc | Health Care | 3.7% |
| Credo Technology Group Holding Ltd | Information Technology | 3.0% |
| Comfort Systems USA Inc | Industrials | 2.6% |
| Madrigal Pharmaceuticals Inc | Health Care | 2.4% |
| Bridgebio Pharma Inc | Health Care | 2.2% |
| Carpenter Technology Corp | Industrials | 2.1% |
| Reddit Inc | Communication Services | 1.9% |
| Modine Manufacturing Co | Industrials | 1.9% |
| GeneDx Holdings Corp | Health Care | 1.9% |
| Kratos Defense & Security Solutions Inc | Industrials | 1.8% |
| MasTec Inc | Industrials | 1.8% |
| SiTime Corp | Information Technology | 1.8% |
| iRhythm Technologies Inc | Health Care | 1.8% |
| Mirion Technologies Inc | Information Technology | 1.8% |
| Tarsus Pharmaceuticals Inc | Health Care | 1.8% |
| Construction Partners Inc | Industrials | 1.7% |
| FTAI Aviation Ltd | Industrials | 1.7% |
| Fabrinet | Information Technology | 1.7% |
| Nova Ltd | Information Technology | 1.7% |
| Unity Software Inc | Information Technology | 1.7% |
| Karman Holdings Inc | Industrials | 1.7% |
| Rambus Inc | Information Technology | 1.6% |
| Guidewire Software Inc | Information Technology | 1.6% |
| Terns Pharmaceuticals Inc | Health Care | 1.6% |
| Planet Fitness Inc | Consumer Discretionary | 1.5% |
| JFrog Ltd | Information Technology | 1.4% |
| MACOM Technology Solutions Holdings Inc | Information Technology | 1.4% |
| RBC Bearings Inc | Industrials | 1.4% |
| Astera Labs Inc | Information Technology | 1.4% |
| Penumbra Inc | Health Care | 1.3% |
| Natera Inc | Health Care | 1.3% |
| PTC Therapeutics Inc | Health Care | 1.3% |
| Crane Co | Industrials | 1.3% |
| Calix Inc | Information Technology | 1.3% |
| Nextpower Inc | Industrials | 1.3% |
| Abivax SA | Health Care | 1.3% |
| IES Holdings Inc | Industrials | 1.2% |
| Evercore Inc | Financials | 1.2% |
| Mercury Systems Inc | Industrials | 1.2% |
| Cogent Biosciences Inc | Health Care | 1.2% |
| Woodward Inc | Industrials | 1.2% |
| Revolution Medicines Inc | Health Care | 1.2% |
| Rocket Lab Corp | Industrials | 1.1% |
| Rhythm Pharmaceuticals Inc | Health Care | 1.1% |
| Adaptive Biotechnologies Corp | Health Care | 1.1% |
| Mirum Pharmaceuticals Inc | Health Care | 1.1% |
| Insmed Inc | Health Care | 1.1% |
| Piper Sandler Cos | Financials | 1.0% |
| Nuvalent Inc | Health Care | 1.0% |
| Hinge Health Inc | Health Care | 1.0% |
| Lyft Inc | Industrials | 1.0% |
| Rubrik Inc | Information Technology | 1.0% |
| Ascendis Pharma A/S | Health Care | 0.9% |
| ServiceTitan Inc | Information Technology | 0.9% |
| Celsius Holdings Inc | Consumer Staples | 0.8% |
| D-Wave Quantum Inc | Information Technology | 0.8% |
| Arcellx Inc | Health Care | 0.8% |
| Sportradar Group AG | Consumer Discretionary | 0.8% |
| Miami International Holdings Inc | Financials | 0.8% |
| Sterling Infrastructure Inc | Industrials | 0.8% |
| AeroVironment Inc | Industrials | 0.8% |
| Semtech Corp | Information Technology | 0.8% |
| Sanmina Corp | Information Technology | 0.7% |
| Lattice Semiconductor Corp | Information Technology | 0.7% |
| TransMedics Group Inc | Health Care | 0.7% |
| Universal Technical Institute Inc | Consumer Discretionary | 0.7% |
| Figure Technology Solutions Inc | Financials | 0.7% |
| Bloom Energy Corp | Industrials | 0.6% |
| HeartFlow Inc | Health Care | 0.6% |
| Dutch Bros Inc | Consumer Discretionary | 0.6% |
| Xometry Inc | Industrials | 0.5% |
| Argan Inc | Industrials | 0.5% |
| Life Time Group Holdings Inc | Consumer Discretionary | 0.5% |
| Loar Holdings Inc | Industrials | 0.5% |
| Agilysys Inc | Information Technology | 0.5% |
| Applied Digital Corp | Information Technology | 0.4% |
| Netskope Inc | Information Technology | 0.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2025
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
|
|
| Consumer Staples |
|
|
| Energy | 0.0% | |
| Financials |
|
|
| Health Care |
|
|
| Industrials |
|
|
| Information Technology |
|
|
| Materials |
|
Portfolio Details as of 12/31/2025
- Total Net Assets
- $1.98 B
- Number of Holdings
- 77
- Weighted Average Market Cap.
- 12.7 B
- P/B Ratio
- 10.0x
- P/E Ratio
- 46.7x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 01/30/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/25/2024 | 11/26/2024 | 11/26/2024 | $0.00570 | $24.23 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $3.3406 | - | $3.3406 | $27.44 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 01/30/2026
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $28.23 |
| $50,000 to $99,999 | 4.75% | 4.00% | $27.94 |
| $100,000 to $249,999 | 3.95% | 3.25% | $27.70 |
| $250,000 to $499,999 | 2.75% | 2.25% | $27.36 |
| $500,000 to $999,999 | 1.95% | 1.75% | $27.14 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $26.61 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 12/31/2025
| Fund Gross Expense Ratio | 0.94% |
| Fund Net Expense Ratio | 0.94% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|
||||
|
Commentary
Publish Date:11/03/2015
|
||||
|
Fund Story
Publish Date:11/03/2015
|